Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 50.50% vs 1.70% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 366.84% vs 5.80% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 22.45% vs 50.18% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -48.48% vs 35.32% in Mar 2024
Compare Balance Sheet Results of Jenburkt Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.41
16.08
-11.67
-72.57%
Share Warrants & Outstandings
Total Reserve
167.36
236.51
-69.15
-29.24%
Shareholder's Funds
171.78
252.94
-81.16
-32.09%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
27.77
-27.77
-100.00%
Secured Loans
0.00
27.77
-27.77
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.38
-2.88
2.50
86.81%
Other Long Term Liabilities
4.50
0.00
4.50
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.25
-0.25
-100.00%
Total Non-Current Liabilities
4.12
25.14
-21.02
-83.61%
Current Liabilities
Trade Payables
8.16
47.42
-39.26
-82.79%
Other Current Liabilities
7.08
7.01
0.07
1.00%
Short Term Borrowings
1.98
21.32
-19.34
-90.71%
Short Term Provisions
1.60
1.44
0.16
11.11%
Total Current Liabilities
18.82
77.20
-58.38
-75.62%
Total Liabilities
194.72
355.28
-160.56
-45.19%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
37.67
45.57
-7.90
-17.34%
Less: Accumulated Depreciation
25.15
26.07
-0.92
-3.53%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
12.52
19.51
-6.99
-35.83%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
40.28
47.29
-7.01
-14.82%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
20.56
71.85
-51.29
-71.38%
Long Term Loans & Advances
5.80
54.23
-48.43
-89.30%
Other Non Current Assets
56.89
0.02
56.87
284,350.00%
Total Non-Current Assets
138.19
192.90
-54.71
-28.36%
Current Assets Loans & Advances
Current Investments
0.00
49.52
-49.52
-100.00%
Inventories
8.88
15.31
-6.43
-42.00%
Sundry Debtors
20.73
83.40
-62.67
-75.14%
Cash and Bank
24.65
7.46
17.19
230.43%
Other Current Assets
1.48
0.20
1.28
640.00%
Short Term Loans and Advances
0.79
6.50
-5.71
-87.85%
Total Current Assets
56.53
162.38
-105.85
-65.19%
Net Current Assets (Including Current Investments)
37.71
85.18
-47.47
-55.73%
Total Current Assets Excluding Current Investments
56.53
112.86
-56.33
-49.91%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
194.72
355.28
-160.56
-45.19%
Contingent Liabilities
16.50
0.76
15.74
2,071.05%
Total Debt
1.98
49.09
-47.11
-95.97%
Book Value per share (adjusted)
389.23
153.92
235.31
152.88%
Annual - Borrowings
Borrowings 1.98 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 4.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 50.50% vs 1.70% in Mar 2024
Annual - Fixed Assets
Fixed Assets 52.80 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 366.84% vs 5.80% in Mar 2024
Annual - Investments
Investments 20.56 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 22.45% vs 50.18% in Mar 2024
Annual - Current Assets
Current Assets 56.53 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -48.48% vs 35.32% in Mar 2024
